Sign in

CIK 0000943819

  • Large accelerated filer
Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
980152841
Phone
+1 858-746-2400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,744,605
in 5 filings, $3.7M under 10b5-1 plans

Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-01 Sandercock Brett Chief Financial Officer Sale 10b5-1 −1,000 $224.31 $224K 83,495
2026-03-02 Sandercock Brett Chief Financial Officer Sale 10b5-1 −1,000 $254.30 $254K 84,495
2026-02-02 Sandercock Brett Chief Financial Officer Sale 10b5-1 −1,000 $257.03 $257K 85,495
2026-01-02 Sandercock Brett Chief Financial Officer Sale 10b5-1 −1,000 $241.75 $242K 86,495
2025-12-01 Sandercock Brett Chief Financial Officer Sale 10b5-1 −1,000 $244.16 $244K 87,495
2025-11-20 Sandercock Brett Chief Financial Officer Grant or award +2,710 88,495
2025-11-03 Sandercock Brett Chief Financial Officer Option exercise 10b5-1 +2,000 $101.64 $203K 88,745
2025-11-03 Sandercock Brett Chief Financial Officer Sale 10b5-1 −3,000 $247.54 $743K 85,745
2025-11-03 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options 10b5-1 −2,000 0
2025-10-01 Sandercock Brett Chief Financial Officer Option exercise 10b5-1 +2,000 $101.64 $203K 89,745
2025-10-01 Sandercock Brett Chief Financial Officer Sale 10b5-1 −3,000 $274.36 $823K 86,745
2025-10-01 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options 10b5-1 −2,000 2,000
2025-09-02 Sandercock Brett Chief Financial Officer Option exercise 10b5-1 +2,000 $101.64 $203K 90,745
2025-09-02 Sandercock Brett Chief Financial Officer Sale 10b5-1 −3,000 $270.77 $812K 87,745
2025-09-02 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options 10b5-1 −2,000 4,000
2025-08-15 Sandercock Brett Chief Financial Officer Grant or award +5,462 88,745
2025-08-01 Sandercock Brett Chief Financial Officer Option exercise 10b5-1 +2,000 $101.64 $203K 86,283
2025-08-01 Sandercock Brett Chief Financial Officer Sale 10b5-1 −3,000 $281.90 $846K 83,283
2025-08-01 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options 10b5-1 −2,000 6,000
2025-07-01 Sandercock Brett Chief Financial Officer Option exercise 10b5-1 +1,966 $101.64 $200K 87,249

Page 1 of 4 · 64 trades